The Cost and Quality of Life of Malaysian Type 2 Diabetes Mellitus Patients with Chronic Kidney Disease and Anemia

Value in Health Regional Issues
Soraya AzmiMohd Radzniwan A Rashid

Abstract

Anemia is common among patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD) and an independent risk factor for renal disease progression. Health economic evidence is important in Malaysia and yet cost and quality-of-life (QOL) data are scarce. To investigate prevalence, factors associated with anemia, and cost and QOL among T2DM patients with CKD. Here, we present the estimated 1-year cost and QOL related to anemia in this group. A cross-sectional, observational study was performed at 20 government clinics. Treatment cost was calculated on the basis of resource utilization ascertained through data extracted from medical records and patient recall. QOL was elicited using the short form 36 health survey version 2 questionnaire. Propensity score matching was performed and costs and QOL were analyzed by anemia status and CKD stage. Data for 816 patients were obtained. The propensity score matching enabled a comparison of 257 patients with and without anemia. Annual treatment costs were significantly higher for patients with anemia (Ringgit Malaysia [RM] 4219 [US $983] vs. RM2705 [US $630]; P = 0.01). QOL scores were lower for patients with anemia but not statistically significant (physical component summar...Continue Reading

References

Mar 13, 2003·Kidney International·William F KeaneUNKNOWN RENAAL Study Investigators
Sep 19, 2003·Current Medical Research and Opinion·Paul E StevensNorbert R Lameire
Oct 27, 2004·Journal of the American Society of Nephrology : JASN·Michelle C OddenMichael G Shlipak
Nov 15, 2005·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·William B ErshlerRobert Dubois
Nov 4, 2006·Journal of the American Society of Nephrology : JASN·Patrick LefebvreSamir H Mody
May 1, 2008·Diabetic Medicine : a Journal of the British Diabetic Association·J P NewI E Buchan
Nov 7, 2008·Clinical Journal of the American Society of Nephrology : CJASN·Fredric O FinkelsteinSalim Mujais
Jul 1, 2009·Diabetes Care·Uzma Mehdi, Robert D Toto
Nov 10, 2009·Diabetes Research and Clinical Practice·J E ShawP Z Zimmet
Jul 10, 2010·Journal of the American Board of Family Medicine : JABFM·Duaine D Murphree, Sarah M Thelen
Feb 1, 2012·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Faridah Aryani Md YusofSoraya Azmi
Jun 14, 2013·Kidney International·Lai Seong HooiMuhammad Fadhli M Yusoff
Dec 21, 2013·PloS One·Nor Baizura Md YusopChoo Beng Huat
Oct 30, 2014·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Aqil Mohammad DaherThan Winn
Apr 1, 2014·Hemodialysis International·Wen J LiuAdam Bujang

❮ Previous
Next ❯

Citations

Sep 10, 2019·PloS One·Temesgen FisehaAngesom Gebreweld
Aug 14, 2020·International Journal of Environmental Research and Public Health·Kurubaran GanasegeranIrene Looi
Mar 4, 2021·International Journal of Nephrology and Renovascular Disease·Chuan-Ming HaoSusan Grandy
Nov 8, 2019·Value in Health Regional Issues·Ku Nurhasni Ku Abd RahimSharifa Ezat Wan Puteh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.